Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Clynes

Showing results (151-160 of 191) with videos related to

Pageof 20
Sort By:
Biotechnology Progress|August 25, 2016
Process-relevant concentrations of the leachable bDtBPP impact negatively on CHO cell production characteristicsPaul S Kelly, Shane McSweeney, Orla Coleman, et al.
BMC Cancer|May 1, 2015
Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progressionSinéad T Aherne, Stephen F Madden, David J Hughes, et al.
Molecular Cancer|December 19, 2006
Investigation of the molecular profile of basal cell carcinoma using whole genome microarraysLorraine O'Driscoll, Jason McMorrow, Padraig Doolan, et al.
BMC Biotechnology|July 26, 2011
Sustained productivity in recombinant Chinese hamster ovary (CHO) cell lines: proteome analysis of the molecular basis for a process-related phenotypePaula Meleady, Padraig Doolan, Michael Henry, et al.
Biotechnology and Bioengineering|January 22, 2010
Microarray and proteomics expression profiling identifies several candidates, including the valosin-containing protein (VCP), involved in regulating high cellular growth rate in production CHO cell linesPadraig Doolan, Paula Meleady, Niall Barron, et al.
BMC Genomics|October 18, 2014
Identification of proteins found to be significantly altered when comparing the serum proteome from Multiple Myeloma patients with varying degrees of bone diseasePaul Dowling, Catriona Hayes, Kay Reen Ting, et al.
Biotechnology and Bioengineering|February 26, 2019
Transcriptomic analysis of IgG4 Fc-fusion protein degradation in a panel of clonally-derived CHO cell lines using RNASeqColin Clarke, Clair Gallagher, Ronan M Kelly, et al.
Cancer Chemotherapy and Pharmacology|April 17, 2013
The interaction of bortezomib with multidrug transporters: implications for therapeutic applications in advanced multiple myeloma and other neoplasiasRobert O'Connor, Melissa G Ooi, Justine Meiller, et al.
Oncology Letters|December 1, 2016
Quantitative label-free mass spectrometry analysis of formalin-fixed, paraffin-embedded tissue representing the invasive cutaneous malignant melanoma proteomePaul Dowling, Benvon Moran, Edel McAuley, et al.
The AAPS Journal|October 13, 2022
FOLFIRINOX Pharmacodynamic Interactions in 2D and 3D Pancreatic Cancer Cell CulturesTaylor J Allen-Coyle, Jin Niu, Eva Welsch, et al.
Pageof 20

Showing results (151-160 of 191) with videos related to

Sort By:
Pageof 20
Biotechnology Progress|August 25, 2016
Process-relevant concentrations of the leachable bDtBPP impact negatively on CHO cell production characteristicsPaul S Kelly, Shane McSweeney, Orla Coleman, et al.
BMC Cancer|May 1, 2015
Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progressionSinéad T Aherne, Stephen F Madden, David J Hughes, et al.
Molecular Cancer|December 19, 2006
Investigation of the molecular profile of basal cell carcinoma using whole genome microarraysLorraine O'Driscoll, Jason McMorrow, Padraig Doolan, et al.
BMC Biotechnology|July 26, 2011
Sustained productivity in recombinant Chinese hamster ovary (CHO) cell lines: proteome analysis of the molecular basis for a process-related phenotypePaula Meleady, Padraig Doolan, Michael Henry, et al.
Biotechnology and Bioengineering|January 22, 2010
Microarray and proteomics expression profiling identifies several candidates, including the valosin-containing protein (VCP), involved in regulating high cellular growth rate in production CHO cell linesPadraig Doolan, Paula Meleady, Niall Barron, et al.
BMC Genomics|October 18, 2014
Identification of proteins found to be significantly altered when comparing the serum proteome from Multiple Myeloma patients with varying degrees of bone diseasePaul Dowling, Catriona Hayes, Kay Reen Ting, et al.
Biotechnology and Bioengineering|February 26, 2019
Transcriptomic analysis of IgG4 Fc-fusion protein degradation in a panel of clonally-derived CHO cell lines using RNASeqColin Clarke, Clair Gallagher, Ronan M Kelly, et al.
Cancer Chemotherapy and Pharmacology|April 17, 2013
The interaction of bortezomib with multidrug transporters: implications for therapeutic applications in advanced multiple myeloma and other neoplasiasRobert O'Connor, Melissa G Ooi, Justine Meiller, et al.
Oncology Letters|December 1, 2016
Quantitative label-free mass spectrometry analysis of formalin-fixed, paraffin-embedded tissue representing the invasive cutaneous malignant melanoma proteomePaul Dowling, Benvon Moran, Edel McAuley, et al.
The AAPS Journal|October 13, 2022
FOLFIRINOX Pharmacodynamic Interactions in 2D and 3D Pancreatic Cancer Cell CulturesTaylor J Allen-Coyle, Jin Niu, Eva Welsch, et al.
Pageof 20